Diagnosing IgAN: The Importance of Early and Accurate Identification
James Chevalier, MD
PeerInvestigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
John Sim, MD
PeerDiagnosing Castleman Disease: Key Considerations
Mateo Bustamante
PeerJoshua Brandstadter, MD, PhD, MSc
PeerIgAN Explained: Key Differences from Other Kidney Conditions
Mohamed Ibrahim, MB, BCh
PeerCAR T-Cell Therapy for R/R Mantle Cell Lymphoma: Key Considerations
Nutritional Strategies for Managing IgA Nephropathy
Rare Kidney Disease: A Parent and Caregiver’s Perspective
ISM Care: Best Practices for Taking a Multidisciplinary Approach